PTPLB inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of PTPLB (Protein Tyrosine Phosphatase-like B), a phosphatase that plays an essential role in regulating cellular signaling pathways, particularly those involved in protein phosphorylation. PTPLB belongs to the larger family of protein tyrosine phosphatases (PTPs), which are enzymes responsible for removing phosphate groups from tyrosine residues on proteins. This dephosphorylation process is critical for maintaining the balance of phosphorylation states in proteins, which in turn regulates key cellular processes such as growth, differentiation, metabolism, and cell cycle control. PTPLB is believed to be involved in modulating specific signaling pathways that control these cellular processes, influencing how cells respond to external stimuli and maintain homeostasis. By inhibiting PTPLB, researchers can disrupt the dephosphorylation of certain substrates, providing a tool to study the specific contributions of PTPLB to cellular signaling and its impact on various biochemical pathways.
In research settings, PTPLB inhibitors are valuable for exploring the molecular mechanisms by which PTPLB regulates protein phosphorylation and the broader implications of this regulation on cellular function. By blocking PTPLB activity, scientists can investigate how inhibition affects the phosphorylation status of target proteins and the downstream signaling pathways that rely on precise phosphorylation-dephosphorylation cycles. This inhibition allows researchers to study the downstream effects on processes such as cell proliferation, metabolism, and the cellular response to environmental changes, where PTPLB-mediated signaling plays a critical role. Additionally, PTPLB inhibitors provide insights into the interactions between PTPLB and other phosphatases or kinases, shedding light on the complex regulatory networks that control cellular signaling dynamics. Through these studies, the use of PTPLB inhibitors enhances our understanding of the role of protein tyrosine phosphatases in maintaining cellular homeostasis, the regulation of phosphorylation-based signaling pathways, and the broader implications of these processes for cellular function and adaptation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide may inhibit the transcription of HACD2 by interfering with RNA polymerase II, leading to a decrease in gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could downregulate HACD2 expression by inhibiting the mTOR pathway, which is involved in lipid metabolism and gene expression. | ||||||
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $75.00 $120.00 | 8 | |
Isotretinoin, a retinoic acid derivative, may alter gene expression, potentially reducing HACD2 mRNA levels through retinoid receptors. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, possibly affecting the stability and expression of enzymes like HACD2. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
Fumonisin B1 inhibits ceramide synthase, which could disrupt lipid signaling pathways, indirectly affecting HACD2 expression. | ||||||
Citilistat | 282526-98-1 | sc-358100 sc-358100A | 250 mg 1 g | $47.00 $104.00 | ||
C75 is a synthetic inhibitor of fatty acid synthase and could influence the expression of enzymes in lipid metabolism, such as HACD2. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
TOFA is an inhibitor of acetyl-CoA carboxylase, which may indirectly downregulate lipid-related enzymes like HACD2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of the MEK/ERK pathway, which may affect transcription factors that regulate genes like HACD2. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin inhibits HMG-CoA reductase, potentially altering lipid biosynthetic pathways and the expression of related enzymes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate numerous signal transduction pathways, potentially affecting transcription factors that regulate HACD2 expression. | ||||||